Form 4 for LRCX Lam Research
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0000707549-22-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-05 | 2022-04-01 | LRCX | Meikle Scott Gerald | SVP | M - OptEx | $176.75 | +700 | 21.1K | +3% | +$123.7K |
| D | 2022-04-05 | 2022-04-01 | LRCX | Meikle Scott Gerald | SVP | S - Sale+OE | $541.22 | -700 | 20.4K | -3% | -$378.9K |
| D | 2022-04-05 | 2022-04-01 | LRCX | Meikle Scott Gerald | SVP | M - OptEx | $176.75 | -700 | 5,600 | -11% | -$123.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | M | A | 700 | $176.75 | 21,125 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2021. (F2) The amount reported includes shares subject to unvested Restricted Stock Units. |
| 2 | Common | Common Stock | 2022-04-01 | S | D | 700 | $541.22 | 20,425 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2021. (F2) The amount reported includes shares subject to unvested Restricted Stock Units. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2022-04-01 | M | D | 700 | $176.75 | 5,600 | D | $176.75 · — to 2026-03-01 | 700 Common Stock | (F3) The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022. |